view map
  • Finland
  • Norway
  • Sweden
  • Estonia
  • Russian Federation
  • Latvia
  • Denmark
  • Lithuania
  • United Kingdom
  • Netherlands
  • Ireland
  • Poland
  • Germany
  • Belgium
  • Czech Republic
  • Ukraine
  • Slovakia
  • Luxembourg
  • Moldova, Republic of
  • Austria
  • France
  • Switzerland
  • Romania
  • Slovenia
  • Croatia
  • Serbia
  • Bosnia & Herzegovina
  • Bulgaria
  • Italy
  • Macedonia, the Former Yugoslav Republic of
  • Spain
  • Greece
  • Israel

News & Events

  • AVROBIO to Collaborate with Saladax Biomedical

    12 May 2020

    AVROBIO has announced a partnership with Saladax Biomedical to develop a new blood test that will simplify and streamline therapeutic drug monitoring (TDM) during the conditioning phase of the lentiviral gene therapy process.

    Full details can be …

    read more »

  • COVID19 - home treatment webinar

    28 April 2020

    One of the challenges that the COVID19 situation has brought to Gaucher patients is receiving ERT infusions and at the recent EWGGD webinar recommendations were made to provide home treatment wherever possible.

    A Zoom meeting has been set up for …

    read more »

  • COVID19 & home treatment

    28 April 2020

    The International Gaucher Alliance is an umbrella organization with more than 50 members all around the world. The IGA represents the interests of the Gaucher Community.  

    Gaucher disease is a rare disease with an incidence of about 1 in …

    read more »

  • Biennial Members Meeting

    16 April 2020

    Notice is hereby given that the Biennial General Meeting of the International Gaucher Alliance will be held online via Zoom on Saturday 23 May 2020 at 7pm (UK time).

    Details of the meeting including resolutions and business to transact have been …

    read more »

  • Notes from the EWGGD webinar on 1 April

    15 April 2020


    Follow Ministry of Health guidelines for individual countries

    Gaucher patients with co-morbidities and chronic illnesses have been advised to self-isolate 

    Patients with underlying lung disease or splenectomy or other …

    read more »

  • Results of the IGA's Board Election

    14 April 2020

    Following the recent IGA board elections, we are delighted to inform you that we will have eight board directors of IGA:

    1. Suyog Sathe (India)
    2. Yoram Muller (Israel)
    3. Anne-Grethe Lauridsen (Denmark)
    4. Biljana Jovanovic (Serbia)
    5. Aviva …

    read more »

  • The IGA has co-authored 'The Definition of Neuronopathic Gaucher disease'

    7 April 2020

    The IGA has co-authored an article 'The Definition of Neuronopathic Gaucher disease' published in the Journal of Inherited Metabolic Disease.

    CEO, Tanya Collin-Histed writes "Proud to have been a part of this publication. These …

    read more »

  • IGA co-authors a scientific paper titled 'The road to biosimilars in rare diseases – ongoing lessons from Gaucher disease

    6 April 2020

    As biosimilars become a 'hot topic' in the rare disease world, the IGA started to educate its members about them two years ago with a presentation from Prof Dingermann on what biosimilars are at our biennial members meeting in Riga, 2018. We …

    read more »

  • COVID-19: A statement from the EWGGD

    31 March 2020

    A statement from the EWGGD to our Gaucher community...

    "We hope that you are all well and managing in this time of unprecedented upheaval and uncertainty. We are sure that you as patients with Gaucher disease and clinicians caring for …

    read more »

  • Covid-19 - keeping in touch

    31 March 2020

    Dear members 

    As the COVID 19 pandemic continues, a lot of families in our community are facing different challenges and issues. This is a challenge but we all need to find strength in each other to adapt to this inevitable change that came …

    read more »